Related Experiment Video
Updated: Jun 4, 2026
12:02
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
The G1 phase Cdks regulate the centrosome cycle and mediate oncogene-dependent centrosome amplification
Mary K Harrison1, Arsene M Adon, Harold I Saavedra
1Emory University, Department of Radiation Oncology, Winship Cancer Institute, 1701 Uppergate Drive, Atlanta, Georgia, 30322, USA. hsaaved@emory.edu.
Cell Division
|January 29, 2011
Summary
Centrosome amplification, common in human tumors, drives cancer development by causing aneuploidy. Oncogenes and altered tumor suppressors exploit cell cycle controls to promote this instability and initiate tumorigenesis.
Area of Science:
- Cell Biology
- Cancer Biology
- Genetics
Background:
- Centrosome amplification is frequently observed in human tumors.
- Centrosome amplification leads to aneuploidy, a condition of abnormal chromosome numbers.
- Aneuploidy is a hallmark of cancer and contributes to genomic instability.
Purpose of the Study:
- To establish centrosome amplification as a major driver of tumor biogenesis.
- To explore the role of oncogenes and altered tumor suppressors in centrosome amplification and aneuploidy.
- To elucidate the mechanisms by which these genetic alterations signal for abnormal cell division.
Main Methods:
- Review of existing evidence linking genetic alterations to centrosome abnormalities.
- Analysis of the interplay between oncogenes, tumor suppressors, and cell cycle regulation.
- Discussion of the contribution of these pathways to tumor initiation and progression.
Main Results:
- Centrosome amplification is a significant factor in the development of human tumors.
- Oncogenes and altered tumor suppressors are key contributors to genomic instability via centrosome amplification.
- These genetic changes utilize cell cycle machinery to induce aneuploidy.
Conclusions:
- Centrosome amplification is a critical mechanism in tumor formation.
- Targeting oncogenes and tumor suppressors could offer strategies to combat cancer-associated genomic instability.
- Understanding the cell cycle regulation of centrosome amplification is vital for cancer research.
More Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...